Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Sepracor-Looks very promising -- Ignore unavailable to you. Want to Upgrade?

To: Biomaven who wrote (4349)	4/13/2000 9:38:00 PM
From: Biomaven	Respond to of 10280

You can hear Southwell on Radio Wall Street: radiowallstreet.com Not much we don't already know - only new nugget I heard is that he specifically mentioned the pain ICE. Here's an interesting Lilly quote from a Bloomberg article (posted in full on Yahoo Club): Early research indicates the new Prozac may be less likely to cause anxiety and insomnia, said Ed West, a Lilly spokesman. More work will have to be done before Lilly knows for certain whether the new drug has these advantages over the existing Prozac. Lilly expects to seek U.S. approval of the new version of Prozac in 2001, he said. Since its 1988 U.S. introduction, doctors have found that Prozac can cause agitation in some patients. That can exacerbate problems for patients who already may have had some anxiety or trouble sleeping along with depression, said Elisabeth Kunkel, an associate professor of psychiatry and human behavior at Thomas Jefferson University. ``People are not as inclined to use Prozac because of the agitation side effect,' Kunkel said. Peter